HEALTHCARE products maker Lenfa Biotech Corp Sdn Bhd plans to float is shares on the Malaysian Exchange of Securities Dealing and Automated Quotation Bhd (Mesdaq) Market by end of 2006.
The Mesdaq Market of Bursa Malaysia Bhd caters to high-growth companies such as those in the Information Technology and Biotechnology industries.
Lenfa Senior Corporate Adviser Teh Kim Seng said the company aims to raise up to RM20million to finance its expansion overseas especially in China and West Asia.
“We are already making preparations to sell our products in China by next year and later may consider setting up a manufacturing plant either on our own or on a joint-venture vasis,” Teh told reporters in Sungai Buloh, Selangor yesterday.
“With the halal certification for our products we will also expand to West Asia,” said Lenfa chairman Wee Ah Yoong.
Teh and Wee had earlier accompanied Science, Technology and Innovation Deputy Minister Datuk Kong Cho Ha who officiated Lenfa’s new RM14million production facility.
Established 38 years ago, Lenfa specialises in traditional Chinese medicine churning out over 60 products such as chicken, fish and ostrich essenses and all sorts of herbs, of which 40 percent are exported.
For the financial year ended December 2004, the company saw a revenue of RM10million. It makes products under the brandname Camberyn.
“We hope to boost our export market from the current 40 per cent, especially into China which as a healthcare market size up to US$4billion [US$1 = RM3.77] a year,” Teh said.
(Source: News Straits Times)